We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+57.48%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$514M
AUM Growth
-$7.79M
Cap. Flow
-$48M
Cap. Flow %
-9.34%
Top 10 Hldgs %
56.23%
Holding
206
New
96
Increased
32
Reduced
19
Closed
50

Top Buys

Rank Stock Value
1
SRNE
Sorrento Therapeutics, Inc.
SRNE
+$11.2M
2
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$11.1M
3
ASXC
Asensus Surgical, Inc.
ASXC
+$8.33M
4
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$8.2M
5
WIMI
WiMi Hologram Cloud
WIMI
+$8.14M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$31.5M
2
AZN icon
AstraZeneca
AZN
+$18.2M
3
MRNA icon
Moderna
MRNA
+$12.1M
4
XWEL icon
XWELL
XWEL
+$6.41M
5
CVM icon
CEL-SCI Corp
CVM
+$3.62M

Sector Composition

Rank Sector Weight
1 Healthcare 13.44%
2 Technology 2.48%
3 Consumer Staples 2.16%
4 Communication Services 1.48%
5 Financials 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPI
1
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$70.4M 13.69%
5,568
+5,266
+1,744% +$47.6K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.8B
$46.5M 9.05%
2,104
+466
+28% +$82.2K
BIIB icon
3
CALL
Biogen
BIIB
$30.4B
$42.5M 8.26%
1,518
-1,244
-45% -$335K
XNTK icon
4
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$33.2M 6.46%
2,449
+432
+21% +$63.9K
SPY icon
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$33.1M 6.43%
834
-166
-17% -$64K
JJT
6
CALL
DELISTED
iPath Series B Bloomberg Tin Subindex Total ReturnSM ETN
JJT
$16.3M 3.18%
14,336
+10,610
+285% +$682K
GLD icon
7
CALL
SPDR Gold Trust
GLD
$131B
$15.5M 3.01%
966
-1,316
-58% -$221K
SRNE
8
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$15.1M 2.95%
18,306
+9,142
+100% +$96.5K
SRNE
9
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$8.81M 1.71%
+1,064,933
New +$11.2M
PENN icon
10
PUT
PENN Entertainment
PENN
$2.82B
$7.66M 1.49%
731
– –
VANI icon
11
Vivani Medical
VANI
$113M
$7.61M 1.48%
+307,398
New +$4.59M
ASXC
12
DELISTED
Asensus Surgical, Inc.
ASXC
$7.48M 1.46%
+2,301,061
New +$8.33M
NBEV
13
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$6.76M 1.32%
+2,364,694
New +$7.23M
KNDI
14
PUT
Kandi Technologies Group
KNDI
$63.5M
$6.71M 1.31%
10,737
+534
+5% +$4.1K
WIMI
15
WiMi Hologram Cloud
WIMI
$21M
$6.47M 1.26%
+98,079
New +$8.14M
VXX icon
16
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$159M
$5.99M 1.16%
+8,203
New +$8.2M
CBAT icon
17
PUT
CBAK Energy Technology Ltd
CBAT
$43.6M
$5.93M 1.15%
11,632
+8,694
+296% +$56.6K
ORIO
18
PUT
Orion Digital Corp
ORIO
$15.6M
$5.36M 1.04%
+2,101
New +$45.8K
RIOT icon
19
PUT
Riot Platforms
RIOT
$8.03B
$4.79M 0.93%
+900
New +$36.4K
RDHL
20
Redhill Biopharma
RDHL
$4.44M
$4.62M 0.9%
+631
New +$5.29M
ZVRA icon
21
PUT
Zevra Therapeutics
ZVRA
$575M
$4.62M 0.9%
+5,023
New +$43.9K
PENN icon
22
PENN Entertainment
PENN
$2.82B
$4.24M 0.82%
+40,399
New +$4.47M
ZVRA icon
23
CALL
Zevra Therapeutics
ZVRA
$575M
$3.86M 0.75%
+4,193
New +$36.6K
IONS icon
24
PUT
Ionis Pharmaceuticals
IONS
$9.14B
$3.73M 0.73%
830
+618
+292% +$34.5K
PCVX icon
25
Vaxcyte
PCVX
$7.88B
$3.54M 0.69%
+178,992
New +$4.5M
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sabby Management held 206 positions worth $514M, down 1.5% from $522M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sabby Management withdrew a net $48M in Q1 2021, closing 50 positions and reducing 19 holdings. Its most notable exit was Biogen, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Sabby Management opened a new position in Sorrento Therapeutics, Inc. worth $8.81M.

  • Sabby Management's largest Q1 2021 buy was Sorrento Therapeutics, Inc.: 1,064,933 shares worth $8.81M.
  • Sabby Management added most to Odonate Therapeutics, Inc. Common Stock in Q1 2021, an estimated $11.1M increase.
  • Sabby Management's biggest Q1 2021 reduction was AVEO Pharmaceuticals, Inc., cutting an estimated $494K.
  • Sabby Management fully exited Biogen in Q1 2021, selling an estimated $31.5M.
  • Sabby Management's ten largest holdings make up 56% of its $514M portfolio in Q1 2021.
  • Sabby Management opened 96 new positions and closed 50 in Q1 2021.
  • Sabby Management's portfolio value fell 1.5% quarter-over-quarter to $514M.

Based on Sabby Management's 13F filing for Q1 2021, filed 17 May 2021.